Netherlands· NL-fb55423f64f9
Selexid 400 mg filmomhulde tabletten
A pivmecillinam product containing pivmecillinamhydrochloride, registered in Netherlands by Karo Pharma AB. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Pivmecillinam is registered in 12 of 19 countries.
Countries holding a registration under ATC J01CA08 (pivmecillinam), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Pivmecillinam · ATC J01CA08
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PIVMECILLINAMHYDROCHLORIDE
- Manufacturer
- Karo Pharma AB
- Country
- Netherlands (NL)
- ATC code
- J01CA08
- ATC class
- Pivmecillinam
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id113967
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pivmecillinam in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSELEXID 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKaro Pharma Ab
- IcelandSelexidKaro Pharma AB*
- NorwaySelexidKaro Pharma AB (1)
- PolandX-SystoKaro Pharma AB
- United KingdomPivmecillinam 200mg tabletsMilpharm Ltd
- FinlandSelexidLeo Pharma A/S
- FranceSELEXID 200 mg, comprimé pelliculéKARO PHARMA (SUEDE)
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Portugal · Selexid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c79ac4e8-876b-45b4-83fd-f002fc7e5845 GET /v1/drugs/c79ac4e8-876b-45b4-83fd-f002fc7e5845?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h113967_smpc.pdf",
"strength": null,
"atc_label": "Pivmecillinam",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg113967",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROLOSE (E 463)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"MAGNESIUMSTEARAAT (E 470b)",
"PARAFFINE, SYNTHETISCH",
"SIMETICON EMULSIE"
],
"substances": [
"PIVMECILLINAMHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h113967.pdf",
"authorised_at": "2014/12/03",
"procedure_number": "DK/H/2327/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "113967",
"additional_monitoring": "N"
}See everything about pivmecillinam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.